Forced oscillation technique in spinal muscular atrophy

Chest

Volumn 146, Issue 3, 2014, Pages 795-803

  Gauld, Leanne M ^a,b   Keeling, Lucy A ^a   Shackleton, Claire E ^a,c   Sly, Peter D ^a,b  

^a Queensland Children's Medical Research Institute   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c QUEENSLAND HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APNEA HYPOPNEA INDEX; ARTICLE; CHEST INFECTION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COBB ANGLE; DISEASE CLASSIFICATION; FEASIBILITY STUDY; FEMALE; FORCED OSCILLATION TECHNIQUE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; LUNG RESISTANCE; MALE; PATIENT MOBILITY; PEAK COUGH FLOW; POLYSOMNOGRAPHY; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SPINAL MUSCULAR ATROPHY; SPIROMETRY; AGE; CHEST WALL OSCILLATION; COUGHING; DISEASE COURSE; EVALUATION STUDY; MUSCULAR ATROPHY, SPINAL; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VITAL CAPACITY;

AGE FACTORS; CHEST WALL OSCILLATION; CHILD; CHILD, PRESCHOOL; COUGH; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MUSCULAR ATROPHY, SPINAL; POLYSOMNOGRAPHY; SPIROMETRY; VITAL CAPACITY;

EID: 84907211067     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0166     Document Type: Article

References (38)

1. Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991; 1 (1): 19-29.
2. Khirani S, Colella M, Caldarelli V, et al. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. Eur J Paediatr Neurol. 2013; 17 (6): 552-560.
3. Munsat TL, Davies KE. International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord. 1992; 2 (5-6): 423-428.
4. Elsheikh B, Prior T, Zhang X, et al. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Muscle Nerve. 2009; 40 (4): 652-656.
5. Nicot F, Hart N, Forin V, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med. 2006; 174 (1): 67-74.
6. Wang CH, Finkel RS, Bertini ES, et al; Participants of the International Conference on SMA Standard of Care. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007; 22 (8): 1027-1049.
7. Robinson D, Galasko CS, Delaney C, Williamson JB, Barrie JL. Scoliosis and lung function in spinal muscular atrophy. Eur Spine J. 1995; 4 (5): 268-273.
8. Tangsrud SE, Carlsen KC, Lund-Petersen I, Carlsen KH. Lung function measurements in young children with spinal muscle atrophy; a cross sectional survey on the effect of position and bracing. Arch Dis Child. 2001; 84 (6): 521-524.
9. Manni R, Cerveri I, Ottolini A, et al. Sleep related breathing patterns in patients with spinal muscular atrophy. Ital J Neurol Sci. 1993; 14 (7): 565-569.
10. Mellies U, Dohna-Schwake C, Stehling F, Voit T. Sleep disordered breathing in spinal muscular atrophy. Neuromuscul Disord. 2004; 14 (12): 797-803.
11. Testa MB, Pavone M, Bertini E, Petrone A, Pagani M, Cutrera R. Sleep-disordered breathing in spinal muscular atrophy types 1 and 2. Am J Phys Med Rehabil. 2005; 84 (9): 666-670.
12. Dohna-Schwake C, Ragette R, Teschler H, Voit T, Mellies U. Predictors of severe chest infections in pediatric neuromuscular disorders. Neuromuscul Disord. 2006; 16 (5): 325-328.
13. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995; 152 (3): 1107-1136.
14. Beydon N, Davis SD, Lombardi E, et al; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007; 175 (12): 1304-1345.
15. American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002; 166 (4): 518-624.
16. Calogero C, Simpson SJ, Lombardi E, et al. Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 years. Pediatr Pulmonol. 2013; 48 (7): 707-715.
17. National regional profi le: Queensland. Australian Bureau of Statistics website. http://www.abs.gov.au/AUSSTATS/abs@nrp.nsf/Latestproducts/3Population/People12007-2011?opendocument&tabname=Summary&prodno=3&issue= 2007-2011. Published 2012. Accessed August 27, 2013.
18. Cobb JR. Outline for the study of scoliosis. In: Instructional Courses Lectures, American Academy of Orthopaedic Surgeons. Vol 5. Ann Arbor, MI: JW Edwards; 1948: 261-275
19. Gauld LM, Kappers J, Carlin JB, Robertson CF. Height prediction from ulna length. Dev Med Child Neurol. 2004; 46 (7): 475-480.
20. Hall GL, Sly PD, Fukushima T, et al. Respiratory function in healthy young children using forced oscillations. Thorax. 2007; 62 (6): 521-526.
21. Frey U. Forced oscillation technique in infants and young children. Paediatr Respir Rev. 2005; 6 (4): 246-254.
22. Miller MR, Hankinson J, Brusasco V, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26 (2): 319-338.
23. Gauld LM, Kappers J, Carlin JB, Robertson CF. Prediction of childhood pulmonary function using ulna length. Am J Respir Crit Care Med. 2003; 168 (7): 804-809.
24. Berry RB, Budhiraja R, Gottlieb DJ, et al; American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Defi nitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012; 8 (5): 597-619.
25. Stefanutti D, Fitting JW. Sniff nasal inspiratory pressure. Reference values in Caucasian children. Am J Respir Crit Care Med. 1999; 159 (1): 107-111.
26. Schramm CM. Current concepts of respiratory complications of neuromuscular disease in children. Curr Opin Pediatr. 2000; 12 (3): 203-207.
27. Gibson GJ, Pride NB, Davis JN, Loh LC. Pulmonary mechanics in patients with respiratory muscle weakness. Am Rev Respir Dis. 1977; 115 (3): 389-395.
28. Kaufmann P, McDermott MP, Darras BT, et al; Muscle Study Group; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011; 68 (6): 779-786.
29. Steffensen BF, Lyager S, Werge B, Rahbek J, Mattsson E. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002; 44 (9): 623-632.
30. Chatwin M, Ross E, Hart N, Nickol AH, Polkey MI, Simonds AK. Cough augmentation with mechanical insuffl ation/exsuffl ation in patients with neuromuscular weakness. Eur Respir J. 2003; 21 (3): 502-508.
31. Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2000; 161 (1): 166-170.
32. Lyager S, Steffensen B, Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest. 1995; 108 (3): 779-785.
33. Keeling LA, Sly PD, Shackleton CE, Gauld LM. Height prediction from ulna length in young children. Respirology. 2012;17.
34. Chen TH, Chang JG, Yang YH, et al. Randomized, double-blind, placebocontrolled trial of hydroxyurea in spinal muscular atrophy. Neurology. 2010; 75 (24): 2190-2197.
35. Swoboda KJ, Scott CB, Crawford TO, et al; Project Cure Spinal Muscular Atrophy Investigators Network. SMA CARNI-VAL trial part I: doubleblind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy. PLoS ONE. 2010; 5 (8): e12140.
36. Swoboda KJ, Scott CB, Reyna SP, et al. Phase II open label study of valproic acid in spinal muscular atrophy. PLoS ONE. 2009; 4 (5): e5268.
37. Kissel JT, Scott CB, Reyna SP, et al; Project Cure Spinal Muscular Atrophy Investigators' Network. SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy. PLoS ONE. 2011; 6 (7): e21296.
38. Liang W-C, Yuo C-Y, Chang J-G, et al. The effect of hydroxyurea in spinal muscular atrophy cells and patients. J Neurol Sci. 2008; 268 (1-2): 87-94.